HCMSG - Hepatitis C Mentor & Support Group, Inc.

  • Home
  • OUR SERVICES
    • The Circle Model >
      • Circle Model Data Form
    • RESOURCES
    • HepCTraining >
      • Live Training
    • Order Materials
    • Webinars
  • Blog
  • About Us
    • Our Mission
    • Board of Directors
    • Medical Advisors
    • Support Us
    • Contact Us
  • Home
  • OUR SERVICES
    • The Circle Model >
      • Circle Model Data Form
    • RESOURCES
    • HepCTraining >
      • Live Training
    • Order Materials
    • Webinars
  • Blog
  • About Us
    • Our Mission
    • Board of Directors
    • Medical Advisors
    • Support Us
    • Contact Us

Pandemic Era Tests May Speed Hepatitis-C Detection

2/8/2022

0 Comments

 
A wave of diagnostics ushered in by Covid could help revive flagging efforts to eliminate the disease.
 ​By Ted Alcorn Feb. 4, 2022 NY TIMES 

​The day after Christmas, when Kellie Trent was scheduled to pick up medication to cure her hepatitis C, it seemed like a little miracle.
She was expected at the Pioneer Family Practice in western Washington State, seven months after screening positive for the blood-borne infection at a clinic that dispenses medication to treat her heroin addiction. All that time, as she underwent more tests and waited for results while in and out of residential drug treatment, addressing her hepatitis C remained out of reach.

​On the eve of her December appointment, her physician, Dr. Lucinda Grande, grew concerned when a storm brought four inches of snow to the region, snarling the roads.

But in the end, Ms. Trent did not show up because she landed in jail for a few days, arrested after missing court appearances for sentencing on a misdemeanor assault charge, according to court records.
Dr. Grande stowed away the first half of the unused prescription — a four-week course of pills priced at $13,000.
“She has had a bumpy road,” Dr. Grande said.
Ms. Trent is among an estimated 2.4 million Americans with hepatitis C, which killed more than 14,000 in 2019, the most recent data available, despite the availability of drugs offering a relatively straightforward cure. The U.S. government set a target of largely vanquishing the disease by 2030, but data from the Centers for Disease Control and Prevention show the number of treated patients has been falling and is less than half the rate necessary to meet that goal.

TO CONTINUE READING:https://www.nytimes.com/2022/02/04/health/hepatitis-c-test.html


0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Archives

    June 2025
    April 2025
    March 2025
    January 2025
    December 2024
    September 2024
    August 2024
    July 2024
    June 2024
    May 2024
    April 2024
    March 2024
    February 2024
    December 2023
    November 2023
    October 2023
    September 2023
    August 2023
    July 2023
    June 2023
    May 2023
    April 2023
    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021

    Categories

    All

    RSS Feed

Privacy Policy
Disclaimer:  Information given by Hepatitis C Mentor and Support Group is not a substitute for advice given by your physician or health care provider.  We do not endorse any doctor, hospital, medical group, or treatment.